Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BMS-754807 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
BMS-754807 is a multi-kinase inhibitor with activity against IGF-1R, insulin receptor, MET, ALK, TRKA, TRKB, AURKA, and AURKB, potentially resulting in decreased tumor cell proliferation (PMID: 25748921, PMID: 31433065). |
| DrugClasses | ALK Inhibitor 33 Aurka Inhibitors 27 Aurkb Inhibitors 21 IGF-1R Inhibitor 17 MET Inhibitor 59 TrkA Receptor Inhibitor 8 |
| CAS Registry Number | 1001350-96-4 |
| NCIT ID | C74043 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AZD8055 + BMS-754807 | AZD8055 BMS-754807 | 0 | 0 |
| BMS-754807 | BMS-754807 | 0 | 0 |
| BMS-754807 + Dacomitinib | BMS-754807 Dacomitinib | 0 | 0 |
| BMS-754807 + Everolimus | BMS-754807 Everolimus | 0 | 0 |
| BMS-754807 + Midostaurin | BMS-754807 Midostaurin | 0 | 0 |
| BMS-754807 + SCH772984 | BMS-754807 SCH772984 | 0 | 0 |